Get the Stockscreener App
1.43
5.93%
0.08
Pre-market:
1.40
-0.03
-2.10%
Shuttle Pharmaceuticals Holdings Inc stock is traded at $1.43, with a volume of 71,211.
It is up +5.93% in the last 24 hours and down -54.17% over the past month.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.
See More
Previous Close:
$1.35
Open:
$1.35
24h Volume:
71,211
Relative Volume:
0.25
Market Cap:
$2.29M
Revenue:
-
Net Income/Loss:
$-7.35M
P/E Ratio:
-3.1087
EPS:
-0.46
Net Cash Flow:
$-5.48M
1W Performance:
-10.63%
1M Performance:
-54.17%
6M Performance:
-66.35%
1Y Performance:
-93.27%
1-Day Range:
$1.35
$1.5694
1-Week Range:
$1.26
$1.5694
52-Week Range:
$1.26
$25.25
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile
Name
Shuttle Pharmaceuticals Holdings Inc
Sector
Phone
(240) 403-4212
Address
401 PROFESSIONAL DRIVE, GAITHERSBURG
Compare SHPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SHPH
Shuttle Pharmaceuticals Holdings Inc
|
1.43 | 2.16M | 0 | -7.35M | -5.48M | -0.46 |
|
ZTS
Zoetis Inc
|
128.18 | 56.27B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.42 | 45.87B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.78 | 43.46B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
26.89 | 30.20B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
486.00 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Latest News
Shuttle Pharmaceuticals CFO resigns, interim CEO steps in as acting CFO By Investing.com - Investing.com UK
Shuttle Pharmaceuticals CFO resigns, interim CEO steps in as acting CFO - Investing.com
Shuttle Pharmaceuticals CFO Resigns, Interim CEO Steps In - TipRanks
Shuttle Pharmaceuticals Holdings IncTimothy Lorber resigns as CFO of Shuttle PharmaceuticalsSEC filing - MarketScreener
You might want to take a look at Shuttle Pharmaceuticals Holdings Inc (SHPH) now - Setenews
Shuttle Pharmaceuticals Completes Strategic Asset Acquisition - TipRanks
Shuttle Pharmaceuticals Holdings Inc. (SHPH) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Shuttle Pharmaceuticals Faces Agreement Termination and Settlement - MSN
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) -12.6% in Normal Trading: Stock Slides Despite Recent Acquisition - Stocks Telegraph
Why Does SHPH Stock Dip? - StocksToTrade
Stocks to Watch: Shuttle Pharma, Butterfly Network, Captivision - 富途牛牛
Shuttle Pharmaceuticals settles Theradex dispute and discontinues Ropidoxuridine trials - Investing.com
Shuttle Pharmaceuticals settles Theradex dispute and discontinues Ropidoxuridine trials By Investing.com - Investing.com UK
[8-K] Shuttle Pharmaceuticals Holdings, Inc. Reports Material Event | SHPH SEC FilingForm 8-K - Stock Titan
Shuttle Pharmaceuticals stock falls after closing Molecule.ai acquisition - Investing.com
Shuttle Pharmaceuticals stock falls after closing Molecule.ai acquisition By Investing.com - Investing.com South Africa
Shuttle Pharmaceuticals acquires AI firm Molecule.ai for $8 million By Investing.com - Investing.com South Africa
Shuttle Pharmaceuticals acquires AI firm Molecule.ai for $8 million - Investing.com
Shuttle Pharmaceuticals Acquires AI Health Platform - TradingView
Shuttle Pharmaceuticals (NASDAQ: SHPH) closes $8M Molecule.ai deal with $2M earnout - Stock Titan
Shuttle Pharmaceuticals (SHPH) Stock Soars on S‑1 Filing, Fresh Financing and AI Pivot – What Today’s Volatile Rally Means for Investors (21 Nov 2025) - ts2.tech
SHPH Stock Surge: AI Acquisition in Focus - timothysykes.com
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Why Shuttle Pharmaceuticals (SHPH) Stock Surged Overnight? - Benzinga
Shuttle Pharmaceuticals Regains Compliance with Nasdaq - MSN
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Using data models to predict Shuttle Pharmaceuticals Holdings Inc. stock movement - newser.com
Is Shuttle Pharmaceuticals Holdings Inc. meeting your algorithmic filter criteria2025 Risk Factors & Intraday High Probability Alerts - newser.com
Why Shuttle Pharmaceuticals Holdings Inc. stock remains undervaluedLayoff News & Verified Momentum Stock Alerts - newser.com
How to integrate Shuttle Pharmaceuticals Holdings Inc. into portfolio analysis toolsShare Buyback & Verified Entry Point Detection - newser.com
Statistical indicators supporting Shuttle Pharmaceuticals Holdings Inc.’s strengthJuly 2025 Summary & Weekly Stock Performance Updates - newser.com
How to manage a losing position in Shuttle Pharmaceuticals Holdings Inc.Trend Reversal & Risk Adjusted Buy/Sell Alerts - newser.com
Best data tools to analyze Shuttle Pharmaceuticals Holdings Inc. stockWeekly Trading Summary & Free Weekly Watchlist of Top Performers - newser.com
Can Shuttle Pharmaceuticals Holdings Inc. stock deliver surprise earnings beatGDP Growth & Stepwise Trade Execution Plans - newser.com
Will Shuttle Pharmaceuticals Holdings Inc. stock return to pre crisis levelsJuly 2025 Momentum & Accurate Entry and Exit Point Alerts - newser.com
Earnings visualization tools for Shuttle Pharmaceuticals Holdings Inc.2025 Year in Review & Smart Money Movement Tracker - newser.com
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.54%
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):